Sales and Marketing

Showing 15 posts of 11524 posts found.

merck_sharp_dohme_deepak_khanna

MSD’s Deepak Khanna to chair American Pharmaceutical Group

March 17, 2011 Research and Development, Sales and Marketing American Pharmaceutical Group, Deepak Khanna, MSD, merck sharp and dohme

Merck Sharp and Dohme’s UK managing director Deepak Khanna has been appointed chairman of the American Pharmaceutical Group. The APG …
Novo Nordisk's type II diabetes drug Victoza (liraglutide)

Novo’s diabetes drug Victoza approved in China

March 16, 2011 Sales and Marketing Glucagon-Like Peptide-1, Novo Nordisk, Victoza, diabetes in China, liraglutide, type 2 diabetes

Novo Nordisk’s injectable diabetes drug Victoza has been given regulatory approval in China. The Chinese State Food and Drug Administration …

New Regulatory & Pharmacovigilance training webinars available

March 15, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Wainwright Associates have designed a multitude of courses on general and specific regulatory & pharmacovigilance topics including:• Analytical Validation• Appeals, Hearings and …
New Zealand haka

Anticipating the competition in pharma

March 14, 2011 Sales and Marketing business intelligence, competitor intelligence, market research

Sun Tzu, the ancient Chinese military strategist wrote: “Conquerors estimate before the war begins, and they consider everything; the defeated …
Yondelis - tunicate Ecteinascidia turbin

NICE rejects PharmaMar’s ovarian cancer drug Yondelis

March 14, 2011 Sales and Marketing Cancer, NICE, PharmaMar, Trabectedin, Yondelis, ovarian cancer

NICE has rejected PharmaMar’s ovarian cancer drug in final draft guidance due to a lack of ‘robust’ data. Yondelis (trabectedin) …

Perry Evans to lead RSA Interims

March 11, 2011 Business Services, Sales and Marketing Perry Evens, RSA Interims, appointment, business services, rsa, sales and marketing

UK-based life science search company RSA has appointed Perry Evans director of RSA Interims. He joined the company in 2006 …

Tangles and plaques: unlocking the secrets of Alzheimer’s disease

March 11, 2011 Research and Development, Sales and Marketing Alzheimer's, Alzheimer's disease, bapineuzumab, dimebon, latrepirdine, solanezumab

Despite many years of relentless research efforts, Alzheimer’s disease, the most common form of dementia, remains impossible to cure. According …
systemic lupus erythematosus (SLE)

US approval for GSK’s lupus treatment Benlysta

March 10, 2011 Sales and Marketing Benlysta, GSK, GlaxoSmithKline, Human Genome Sciences, Lupus, belimumab, systemic lupus erythematosus

GlaxoSmithKline’s lupus treatment Benylsta has won an historic approval in the US, but will have to prove its safety record …

Novartis’ COPD drug recommended for FDA approval

March 10, 2011 Sales and Marketing Arcapta Neohaler, COPD, Novartis, Onbrez Breezhaler, QAB143, chronic obstructive pulmonary disease, indacterol

Novartis has won the backing of an FDA advisory committee for its chronic obstructive pulmonary disease (COPD) treatment QAB149. The …

Janssen’s monthly antipsychotic approved in Europe

March 9, 2011 Sales and Marketing Janssen, Xeplion, antipsychotic, injectible antipsychotic, paliperidone palmitate, schizophrenia

Janssen’s injectable antipsychotic Xeplion has been approved by the European Commission for the treatment of schizophrenia. There is no cure …

Actelion defends itself against investor aggression

March 9, 2011 Sales and Marketing Actelion, Tracleer, almorexant

Swiss biotech firm Actelion is mounting a defence of its management board and strategy following an offensive by a shareholder …

Eisai confirms 20% cut in US workforce

March 8, 2011 Manufacturing and Production, Research and Development, Sales and Marketing Aricept, Eisai, Halaven, US, donepezil, eribulin, pharma job cuts

Eisai’s planned job cuts will fall heaviest on its US operations, where 20% of the workforce will be let go …

Sophie Gibbs and Naumaan Mayet join Pan

March 8, 2011 Medical Communications, Sales and Marketing Naumaan Mayet, Pan, Pan Advertising, Sophie Gibbs, appointment, medical communications

Pan Advertising has recruited two new members to its account handling team.Sophie Gibbs returns to the agency as an account …

Ethical practices – pharma’s obligation

March 8, 2011 Research and Development, Sales and Marketing ethics, industry relations, industry reputation

Pharmaceutical companies are not charities, and neither is any other business, by definition. Capitalism as a recognised system has been …

Service Insight: Emerging markets – a business development task or extreme fishing?

March 7, 2011 Sales and Marketing Service Insight, Surelines Ltd, emerging markets

SERVICE INSIGHTEmerging markets, new business; call it what you will but invariably the responsibility for grasping this nettle falls to …
The Gateway to Local Adoption Series

Latest content